ImageneBio (IMA) Accumulated Depreciation (2020 - 2024)

ImageneBio has disclosed Accumulated Depreciation across 5 years of filings, most recently posting $1.4 million for Q4 2024.

• Accumulated Depreciation for Q4 2024 came in at $1.4 million, down 47.2% year-over-year; the trailing twelve-month figure through Dec 2024 was $1.4 million (down 47.2% YoY), and the FY2024 annual result was $1.4 million, down 47.2% from the prior year.
• Accumulated Depreciation came in at $1.4 million for Q4 2024 at ImageneBio, down from $2.7 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $2.7 million in Q4 2023 to a low of $617000.0 in Q1 2021.
• The 5-year median for Accumulated Depreciation is $1.4 million (2022), against an average of $1.5 million.
• Across the five-year window, Accumulated Depreciation jumped 103.24% in 2022 and slumped 47.2% in 2024, its largest moves.
• ImageneBio's Accumulated Depreciation stood at $688000.0 in 2020, then jumped by 56.1% to $1.1 million in 2021, then surged by 69.93% to $1.8 million in 2022, then jumped by 49.97% to $2.7 million in 2023, then plunged by 47.2% to $1.4 million in 2024.
• The last three Accumulated Depreciation figures came in at $1.4 million (Q4 2024), $2.7 million (Q4 2023), and $2.5 million (Q3 2023), per Business Quant data.